NeuroCap (Model DEC22)— 510(k) K202913

Substantially Equivalent

Memory MD, Inc.

FDA 510(k) clearance K202913 for NeuroCap (Model DEC22), Substantially Equivalent on 2021-03-05. Applicant: Memory MD, Inc..

Clearance details

Applicant: Memory MD, Inc.
Product code: Code GXY
Advisory panel: Neurology
Date received: 2020-09-29
Decision date: 2021-03-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bohemia, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.